About Us

Beijing Genesee Biotech, Inc. is a high-tech enterprise focusing on the development, production and sales of tropical infectious disease diagnostic products.

Our company has two series of in vitro diagnostic reagents, Rapid Test and Elisa, which are exported to more than 100 countries and regions all over the world. The products have many advantages, such as simple and flexible operation, no site restriction, accurate results, etc., and have made outstanding contributions to global disease control, prevention, physical examination and screening.

In September 2020, Beijing Genese Biotech, Inc. (BGB), together with CTK Biotech Inc (CTK), joined the SSI Diagnostica Group with offices and production in Denmark. Today BGB and CTK are wholly owned affiliates of SSI Diagnostica A/S Group. The Group CEO is based out of Hilleroed, Denmark. “Our R&D and technical personnel keep business cooperation all the year round and keep pace with international diagnostic technology. Our company's quality system meets the requirements of American cGMP, and the products developed and produced by our company have been successfully approved by WHO.